BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 97796)

  • 1. Enhancing Plasmapheresis Efficacy in Waldenstrom Macroglobulinemia: Overcoming Circuit Clotting Challenges.
    Khan U; Sharma S; Prasad P; Agarwal A; Jain A; Jain A; Verma H
    Semin Dial; 2024; 37(3):282-283. PubMed ID: 38506146
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of Waldenström's macroglobulinaemia with high-doses cyclic corticosteroids (author's transl)].
    Cicco JA; Rando A; Scionico EA; Quiroga Micheo E; Scionico M
    Sangre (Barc); 1979; 24(2):195-8. PubMed ID: 111359
    [No Abstract]   [Full Text] [Related]  

  • 3. Waldenstrom's macrogloblinaemia: modified plasmapheresis as treatment option in a Nigeria setting.
    Abjah UM; Aken'Ova YA; Ocheni S
    Niger J Med; 2002; 11(4):190-2. PubMed ID: 12955999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alleviation of ocular complications of the hyperviscosity syndrome in Waldenström's macroglobulinemia using plasma exchange].
    Malecaze F; Mathis A; Gonzales C; Lloveras JJ; Goudable C; Arlet P; Bec P
    J Fr Ophtalmol; 1986; 9(5):367-71. PubMed ID: 3100607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of plasmapheresis in macroglobulinemic reticulosis (Waldenström's disease).
    Mokeeva RA; Rutberg RA; Chernyak VY; Maller AR; Papush ND; Soboleva YG; Rakhmaeva VA; Khutsishvili GE
    Fed Proc Transl Suppl; 1966; 25(1):153-6. PubMed ID: 4954863
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperviscosity syndrome in Waldenström's macroglobulinemia.
    Krol TC; Wood WS
    Am Fam Physician; 1981 Aug; 24(2):187-9. PubMed ID: 6789661
    [No Abstract]   [Full Text] [Related]  

  • 7. [Plasmapheresis in the treatment of waldenström's macroglobulinaemia (author's transl)].
    Barbolla L; Fernández MN
    Sangre (Barc); 1978; 23(3):334-42. PubMed ID: 97796
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Gertz MA; Anagnostopoulos A; Anderson K; Branagan AR; Coleman M; Frankel SR; Giralt S; Levine T; Munshi N; Pestronk A; Rajkumar V; Treon SP
    Semin Oncol; 2003 Apr; 30(2):121-6. PubMed ID: 12720120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Waldenström's macroglobulinemia: clinical aspects, diagnosis and therapy].
    Baldus M; Brass H
    Med Klin (Munich); 1992 Aug; 87(8):434-6. PubMed ID: 1406477
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment and outcome patterns in European patients with Waldenström's macroglobulinaemia: a large, observational, retrospective chart review.
    Buske C; Sadullah S; Kastritis E; Tedeschi A; García-Sanz R; Bolkun L; Leleu X; Willenbacher W; Hájek R; Minnema MC; Cheng M; Bilotti E; Graef T; Dimopoulos MA;
    Lancet Haematol; 2018 Jul; 5(7):e299-e309. PubMed ID: 29958569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of plasmapheresis in Waldenström's macroglobulinemia.
    Stone MJ; Bogen SA
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):238-40. PubMed ID: 23522642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Waldenström's macroglobulinemia.
    Johnson SA
    Rev Clin Exp Hematol; 2002 Dec; 6(4):421-34; discussion 449-50. PubMed ID: 12823781
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.